local_hospital

Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz

Address
lock Available on a paid plan

Diagnostic Imaging and Contrast Research

At Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz in Miskolc, clinical research in Analytical, Diagnostic and Therapeutic Techniques and Equipment focuses on improving magnetic resonance imaging for both adult and pediatric patients. These studies are designed to assess the performance and safety of newer contrast agents and to refine imaging support for a range of suspected neurological and non-neurological conditions.

  • Evaluating contrast enhancement for clearer MRI-based diagnosis
  • Studying imaging tools for central nervous system and other body pathologies
  • Assessing diagnostic use in children undergoing contrast-enhanced MRI

The work in this area aims to make imaging more reliable, helping clinicians detect disease earlier and interpret scans with greater confidence.

Oncology and Breast Cancer Studies

Research in Neoplasms covers several cancers, including triple-negative breast cancer, ER+/HER2-negative breast cancer, advanced tumors, and non-clear cell renal cell carcinoma. The trials are mainly focused on testing new treatment combinations and comparing them with established therapies to improve disease control and long-term outcomes.

  • Investigating treatment options for advanced and treatment-resistant cancers
  • Studying therapies for breast cancer recurrence and progression
  • Evaluating approaches for renal and other solid tumors

These studies reflect an active oncology program that seeks better ways to manage cancers where current treatment choices may be limited.

Gastroenterology and Immune-Mediated Disease

The site also runs studies in Immune System Diseases and Nutritional and Metabolic Diseases, with a strong focus on inflammatory bowel conditions such as Crohn's disease and ulcerative colitis. In addition, research includes atopic dermatitis, showing interest in immune-driven diseases that affect both children and adults.

  • Testing therapies for pediatric Crohn's disease and ulcerative colitis
  • Evaluating treatment effectiveness in moderate to severe atopic dermatitis
  • Exploring safer and more effective immune-targeted care

These trials are aimed at improving symptom control, reducing inflammation, and supporting better quality of life for patients with chronic immune-related illness.

Neurology and Stroke Prevention

Clinical research in Cardiovascular Diseases and related vascular conditions includes studies of acute ischemic stroke, high-risk transient ischemic attack, and prevention of stroke in patients with atrial fibrillation. The emphasis is on finding better ways to reduce clot-related events and improve recovery after urgent cerebrovascular disease.

  • Studying treatments for acute stroke and early secondary prevention
  • Preventing stroke and systemic embolism in atrial fibrillation
  • Comparing new approaches with standard care for vascular protection

These investigations support faster, more effective management of stroke risk, an important area for patients at high cardiovascular risk.

Infectious Disease and Respiratory Protection

Another important theme at the hospital in Miskolc is research in Bacterial Infections and Mycoses and Virus Diseases, especially severe community-acquired bacterial pneumonia and prevention of RSV infection in infants and children. These studies examine both treatment support for serious infection and protection strategies for vulnerable pediatric populations.

  • Evaluating care for severe bacterial pneumonia
  • Studying prevention of RSV in high-risk infants and children
  • Assessing safety and tolerability of infection-related interventions

The research helps address infections that can be especially dangerous in young or medically fragile patients.

Cardiometabolic and Endocrine Research

Studies in Nutritional and Metabolic Diseases and Cardiovascular Diseases include type 2 diabetes mellitus, atherosclerotic cardiovascular disease, and elevated lipoprotein(a). The goal is to test new treatment approaches that may improve metabolic control while also lowering future cardiovascular risk.

  • Investigating better control of blood sugar in type 2 diabetes
  • Exploring therapies to reduce cardiovascular events
  • Comparing new options with standard prevention strategies

This area connects diabetes care with heart and vessel health, reflecting a broad approach to long-term disease prevention.

Mixed Specialty Clinical Research

The overall trial portfolio at Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz shows a wide-ranging research profile across diagnosis, oncology, immunology, neurology, infection, and cardiometabolic care. With 25 investigators contributing to 20 clinical trials, the site supports studies that compare new therapies with current standards and aim to improve both treatment effectiveness and patient safety.

  • Multi-disease research across adult and pediatric populations
  • Trials focused on treatment effectiveness and safety
  • Ongoing evaluation of new options in several major therapeutic areas

This diverse activity highlights the site’s role as an active clinical research center serving patients with both common and complex conditions.

Site Overview

assignment
74
connected trials
corporate_fare
30
sponsors
science
149
IMPs

Activity Indicator

Last 6 months

2
Trials started
-67% vs previous period.
6
Trials started 6–12 months ago
74
Total trials linked
Highly Active
trending_downDeclining-67%
1
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 2 of 16 therapeutic areas and 15 of 149 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 146 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
32
Sponsors (total)
30
Active sponsors
23

Sponsor Network

Top 23 by active trials.

lock +22 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +11 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 332 other sites in Hungary

description
Trial volume
74
Outperforms 95% of sites
public
Therapeutic diversity
17areas
Outperforms 98% of sites
groups
Sponsor diversity
30sponsors
Outperforms 94% of sites

Therapeutic Area Benchmark — Hungary

Select a therapeutic area to compare against other sites in Hungary.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Hungary

Market Share

Country: Hungary

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Borsod-Abauj-Zemplen Varmegyei Koezponti Korhaz Es Egyetemi Oktatokorhaz

lock Showing 1 of 74 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 149 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Pembrolizumab9Unknown2016-09-162026-06-16

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.